StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.07−0.59 (-2.37%)

Close on Nov 16, 2026Market cap $662.43MP/E –Yield –

Fulgent Genetics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Fulgent Genetics's profit margin for the twelve months ending Jun 30, 2026 was -26.0%. For fiscal 2025 it was -18.8%, against -15.1% the year before. The highest annual figure on record is 51.1% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-18.8%−3.7
FY2024Dec 31, 2024-15.1%+43.0
FY2023Dec 31, 2023-58.0%−81.2
FY2022Dec 31, 202223.2%−27.9
FY2021Dec 31, 202151.1%+0.3
FY2020Dec 31, 202050.8%+52.1
FY2019Dec 31, 2019-1.3%+25.0
FY2018Dec 31, 2018-26.3%−12.9
FY2017Dec 31, 2017-13.4%+15.9
FY2016Dec 31, 2016-29.3%+57.6
FY2015Dec 31, 2015-86.8%+248.3
FY2014Dec 31, 2014-335.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-34.6%−11.4
Q1 FY2026Mar 31, 2026-34.9%−19.2
Q4 FY2025Dec 31, 2025-28.1%−20.4
Q3 FY2025Sep 30, 2025-7.9%+12.6
Q2 FY2025Jun 30, 2025-23.2%−10.9
Q1 FY2025Mar 31, 2025-15.7%+5.2
Q4 FY2024Dec 31, 2024-7.7%+174.0
Q3 FY2024Sep 30, 2024-20.4%−4.9
Q2 FY2024Jun 30, 2024-12.3%+4.3
Q1 FY2024Mar 31, 2024-20.9%+2.3
Q4 FY2023Dec 31, 2023-181.8%−146.6
Q3 FY2023Sep 30, 2023-15.5%−17.1
Q2 FY2023Jun 30, 2023-16.5%−25.8
Q1 FY2023Mar 31, 2023-23.2%−71.3
Q4 FY2022Dec 31, 2022-35.2%−76.7
Q3 FY2022Sep 30, 20221.6%−52.1
Q2 FY2022Jun 30, 20229.2%−42.8
Q1 FY2022Mar 31, 202248.1%−7.8
Q4 FY2021Dec 31, 202141.5%−14.9
Q3 FY2021Sep 30, 202153.8%+7.9
Q2 FY2021Jun 30, 202152.0%+32.7
Q1 FY2021Mar 31, 202155.8%+81.1
Q4 FY2020Dec 31, 202056.4%+59.9
Q3 FY2020Sep 30, 202045.9%+31.7
Q2 FY2020Jun 30, 202019.2%+15.3
Q1 FY2020Mar 31, 2020-25.2%+10.3
Q4 FY2019Dec 31, 2019-3.5%+32.7
Q3 FY2019Sep 30, 201914.1%+24.7
Q2 FY2019Jun 30, 20193.9%+23.4
Q1 FY2019Mar 31, 2019-35.5%+5.5
Q4 FY2018Dec 31, 2018-36.2%+1.7
Q3 FY2018Sep 30, 2018-10.6%+13.7
Q2 FY2018Jun 30, 2018-19.4%−18.9
Q1 FY2018Mar 31, 2018-41.0%−45.4
Q4 FY2017Dec 31, 2017-37.9%−51.8
Q3 FY2017Sep 30, 2017-24.3%−2.2
Q2 FY2017Jun 30, 2017-0.5%–
Q1 FY2017Mar 31, 20174.4%–
Q4 FY2016Dec 31, 201613.9%–
Q3 FY2016Sep 30, 2016-22.1%–

More Fulgent Genetics figures

See a number that looks wrong?